CN105541818A — 一种卡格列净水合物新晶型及其制备方法
Assigned to Zhejiang Huahai Pharmaceutical Co Ltd · Expires 2016-05-04 · 10y expired
What this patent protects
本发明提供了一种卡格列净水合物新晶型及其制备方法,所述的卡格列净水合物新晶型的TGA图在80-100℃失重为1.35%,其用CuKa射线作为特征X射线粉末测定中,其图谱具有下列2Θ衍射角:3.9±0.2°、7.9±0.2°、13.0±0.2°、15.4±0.2°、20.2±0.2°。本发明方法具有操作简单,收率高,重现性好,更易于商业化大生产等优点,制备出的水合物新晶型理化性质稳定、纯度高。
USPTO Abstract
本发明提供了一种卡格列净水合物新晶型及其制备方法,所述的卡格列净水合物新晶型的TGA图在80-100℃失重为1.35%,其用CuKa射线作为特征X射线粉末测定中,其图谱具有下列2Θ衍射角:3.9±0.2°、7.9±0.2°、13.0±0.2°、15.4±0.2°、20.2±0.2°。本发明方法具有操作简单,收率高,重现性好,更易于商业化大生产等优点,制备出的水合物新晶型理化性质稳定、纯度高。
Drugs covered by this patent
- Invokana (CANAGLIFLOZIN) · Johnson & Johnson
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.